Last reviewed · How we verify

Fentanyl - PICU Standard

Vanderbilt University Medical Center · FDA-approved active Small molecule

Fentanyl is a synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation.

Fentanyl is a synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation. Used for Pain management in pediatric intensive care unit (PICU) patients, Sedation in mechanically ventilated pediatric patients.

At a glance

Generic nameFentanyl - PICU Standard
SponsorVanderbilt University Medical Center
Drug classOpioid agonist
TargetMu-opioid receptor (OPRM1)
ModalitySmall molecule
Therapeutic areaAnesthesia/Critical Care
PhaseFDA-approved

Mechanism of action

Fentanyl activates mu-opioid receptors throughout the brain and spinal cord, inhibiting pain signal transmission and producing potent analgesia. In the PICU setting, it is used for both pain management and sedation in critically ill pediatric patients. The drug has a rapid onset and short duration of action, making it suitable for titrated sedation in mechanically ventilated children.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: